1.
Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density:
a systematic review and meta-analysis. Lancet 2014;383:146-55.
2.
Al Mheid I, Quyyumi AA. Vitamin D and Cardiovascular Disease: Controversy Unresolved.
J Am Coll Cardiol 2017;70:89-100.
3.
Tamez H, Thadhani RI. Vitamin D and hypertension: an update and review. Curr Opin
Nephrol Hypertens 2012;21:492-9.
4.
Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D
in reducing cancer risk and progression. Nat Rev Cancer 2014;14:342-57.
5.
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review.
Eur J Clin Nutr 2011;65:1005-15.
6.
Di Cesar DJ, Ploutz-Snyder R, Weinstock RS, Moses AM. Vitamin D deficiency is more
common in type 2 than in type 1 diabetes. Diabetes Care 2006;29:174.
7.
Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, et al. Circulating 25-hydroxyvitamin
D concentration and the risk of type 2 diabetes: results from the European Prospective
Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective
studies. Diabetologia 2012;55:2173-82.
8.
Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy
vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies.
Diabetes Care 2013;36:1422-8.
9.
Ogurtsova K, da Rocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: Global estimates
for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017;128:40-50.
10.
Kayaniyil S, Retnakaran R, Harris SB, Vieth R, Knight JA, Gerstein HC, et al. Prospective
associations of vitamin D with beta-cell function and glycemia: the PROspective Metabolism
and ISlet cell Evaluation (PROMISE) cohort study. Diabetes 2011;60:2947-53.
11.
von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance
in South Asian women living in New Zealand who are insulin resistant and vitamin D
deficient - a randomised, placebo-controlled trial. Br J Nutr 2010;103:549-55.
12.
Shab-Bidar S, Neyestani TR, Djazayery A, Eshraghian MR, Houshiarrad A, Kalayi A, et
al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic
inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012;28:424-30.
13.
Krul-Poel YH, Ter Wee MM, Lips P, Simsek S. MANAGEMENT OF ENDOCRINE DISEASE: The effect
of vitamin D supplementation on glycaemic control in patients with type 2 diabetes
mellitus: a systematic review and meta-analysis. Eur J Endocrinol 2017;176:R1-R14.
14.
Lee CJ, Iyer G, Liu Y, Kalyani RR, Bamba N, Ligon CB, et al. The effect of vitamin
D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic
review and meta-analysis of intervention studies. J Diabetes Complications 2017;31:1115-26.
15.
Wu C, Qiu S, Zhu X, Li L. Vitamin D supplementation and glycemic control in type 2
diabetes patients: A systematic review and meta-analysis. Metabolism 2017;73:67-76.
16.
Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The Effect of Improved Serum 25-Hydroxyvitamin
D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol
Metab 2017;102:3097-110.
17.
Li X, Liu Y, Zheng Y, Wang P, Zhang Y. The Effect of Vitamin D Supplementation on
Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis.
Nutrients 2018;10:375.
18.
Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in
people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-6.
19.
Moreira-Lucas TS, Duncan AM, Rabasa-Lhoret R, Vieth R, Gibbs AL, Badawi A, et al.
Effect of vitamin D supplementation on oral glucose tolerance in individuals with
low vitamin D status and increased risk for developing type 2 diabetes (EVIDENCE):
A double-blind, randomized, placebo-controlled clinical trial. Diabetes Obes Metab
2017;19:133-41.
20.
Wagner H, Alvarsson M, Mannheimer B, Degerblad M, Ostenson CG. No Effect of High-Dose
Vitamin D Treatment on beta-Cell Function, Insulin Sensitivity, or Glucose Homeostasis
in Subjects With Abnormal Glucose Tolerance: A Randomized Clinical Trial. Diabetes
Care 2016;39:345-52.
21.
Rajan S, Weishaar T, Keller B. Weight and skin colour as predictors of vitamin D status:
results of an epidemiological investigation using nationally representative data.
Public Health Nutr 2017;20:1857-64.
22.
Word Health Organization. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of
Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva 2011.
23.
Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF consensus worldwide definition of
the metabolic syndrome: International Diabetes Federation 2006.
24.
Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type
2 diabetes risk. Diabetes Care 2003;26:725-31.
25.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis
model assessment: insulin resistance and beta-cell function from fasting plasma glucose
and insulin concentrations in man. Diabetologia 1985;28:412-9.
26.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance
testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-70.
27.
Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding
the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-94.
28.
Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, et al. Clinical
review: Effect of vitamin D3 supplementation on improving glucose homeostasis and
preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab
2014;99:3551-60.
29.
Poolsup N, Suksomboon N, Plordplong N. Effect of vitamin D supplementation on insulin
resistance and glycaemic control in prediabetes: a systematic review and meta-analysis.
Diabet Med. 2016 Mar;33(3):290-9.
30.
Mitri J, Dawson-Hughes B, Hu FB, Pittas AG. Effects of vitamin D and calcium supplementation
on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high
risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized
controlled trial. Am J Clin Nutr 2011;94:486-94.
31.
Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebocontrolled trial
of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently
healthy, middle-aged, centrally obese men. Diabet Med 2009;26:19–27.
32.
Nikooyeh B, Neyestani TR, Farvid M, Alavi-Majd H, Houshiarrad A, et al. Daily consumption
of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control
in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr 2011;93:764–771.
33.
Mazahery H, von Hurst PR. Factors Affecting 25-Hydroxyvitamin D Concentration in Response
to Vitamin D Supplementation. Nutrients 2015;7:5111-42.
34.
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol
response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204-10.
35.
Lotito A, Teramoto M, Cheung M, Becker K, Sukumar D. Serum Parathyroid Hormone Responses
to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis
of Randomized Clinical Trials. Nutrients 2017;9:241.
36.
Liu J, Dong H, Zhang Y, Cao M, Song L, Pan Q, et al. Bilirubin Increases Insulin Sensitivity
by Regulating Cholesterol Metabolism, Adipokines and PPARgamma Levels. Sci Rep 2015;5:9886.
37.
Zhu B, Wu X, Bi Y, Yang Y. Effect of bilirubin concentration on the risk of diabetic
complications: A meta-analysis of epidemiologic studies. Sci Rep 2017;7:41681.
38.
Florez JC, Hirschhorn J, Altshuler D. The Inherited Basis of Diabetes Mellitus: Implications
for the Genetic Analysis of Complex Traits. Ann Rev Genom Hum Genetics 2003;4:257-91.